nodes	percent_of_prediction	percent_of_DWPC	metapath
Trandolapril—CES1—Capecitabine—esophageal cancer	0.76	1	CbGbCtD
Trandolapril—ACE—thoracic aorta—esophageal cancer	0.0413	0.414	CbGeAlD
Trandolapril—CES1—larynx—esophageal cancer	0.0206	0.207	CbGeAlD
Trandolapril—CES1—neck—esophageal cancer	0.00547	0.0549	CbGeAlD
Trandolapril—ACE—neck—esophageal cancer	0.00364	0.0365	CbGeAlD
Trandolapril—SLC15A1—epithelium—esophageal cancer	0.00346	0.0347	CbGeAlD
Trandolapril—CES1—digestive system—esophageal cancer	0.00283	0.0284	CbGeAlD
Trandolapril—SLC15A1—digestive system—esophageal cancer	0.00263	0.0264	CbGeAlD
Trandolapril—CES1—Irinotecan Pathway—ABCC2—esophageal cancer	0.00249	0.125	CbGpPWpGaD
Trandolapril—ACE—epithelium—esophageal cancer	0.00248	0.0249	CbGeAlD
Trandolapril—ACE—smooth muscle tissue—esophageal cancer	0.00239	0.0239	CbGeAlD
Trandolapril—CES1—lung—esophageal cancer	0.00237	0.0237	CbGeAlD
Trandolapril—SLC15A2—bronchus—esophageal cancer	0.00213	0.0213	CbGeAlD
Trandolapril—SLC15A2—trachea—esophageal cancer	0.00191	0.0192	CbGeAlD
Trandolapril—ACE—digestive system—esophageal cancer	0.00188	0.0189	CbGeAlD
Trandolapril—CES1—Fluoropyrimidine Activity—XRCC3—esophageal cancer	0.00173	0.0864	CbGpPWpGaD
Trandolapril—CES1—lymph node—esophageal cancer	0.00162	0.0162	CbGeAlD
Trandolapril—ACE—lung—esophageal cancer	0.00157	0.0158	CbGeAlD
Trandolapril—CES1—Fluoropyrimidine Activity—TYMP—esophageal cancer	0.00145	0.0724	CbGpPWpGaD
Trandolapril—SLC15A2—lung—esophageal cancer	0.00137	0.0138	CbGeAlD
Trandolapril—ACE—lymph node—esophageal cancer	0.00108	0.0108	CbGeAlD
Trandolapril—CES1—Fluoropyrimidine Activity—CYP2A6—esophageal cancer	0.001	0.0502	CbGpPWpGaD
Trandolapril—SLC15A2—lymph node—esophageal cancer	0.000939	0.00942	CbGeAlD
Trandolapril—ACE—Peptide hormone metabolism—SLC30A7—esophageal cancer	0.00085	0.0425	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—SMUG1—esophageal cancer	0.000817	0.0409	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—ALDH3A1—esophageal cancer	0.000816	0.0408	CbGpPWpGaD
Trandolapril—ACE—ACE Inhibitor Pathway—NOS3—esophageal cancer	0.000741	0.0371	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—BLVRB—esophageal cancer	0.000727	0.0364	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—XRCC1—esophageal cancer	0.000665	0.0333	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—PRDX1—esophageal cancer	0.000618	0.0309	CbGpPWpGaD
Trandolapril—Menopausal symptoms—Capecitabine—esophageal cancer	0.000559	0.00471	CcSEcCtD
Trandolapril—Vasculitis—Methotrexate—esophageal cancer	0.000554	0.00467	CcSEcCtD
Trandolapril—CES1—NRF2 pathway—SLC39A6—esophageal cancer	0.000551	0.0276	CbGpPWpGaD
Trandolapril—Blood uric acid increased—Methotrexate—esophageal cancer	0.000551	0.00464	CcSEcCtD
Trandolapril—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000544	0.00458	CcSEcCtD
Trandolapril—Arthritis—Capecitabine—esophageal cancer	0.000543	0.00457	CcSEcCtD
Trandolapril—Renal failure—Cisplatin—esophageal cancer	0.000542	0.00457	CcSEcCtD
Trandolapril—Myocardial infarction—Cisplatin—esophageal cancer	0.000541	0.00455	CcSEcCtD
Trandolapril—Cardiac failure—Capecitabine—esophageal cancer	0.00054	0.00455	CcSEcCtD
Trandolapril—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000538	0.00453	CcSEcCtD
Trandolapril—Hyponatraemia—Capecitabine—esophageal cancer	0.00053	0.00446	CcSEcCtD
Trandolapril—Pain in extremity—Capecitabine—esophageal cancer	0.000527	0.00444	CcSEcCtD
Trandolapril—Osteoarthritis—Capecitabine—esophageal cancer	0.000527	0.00444	CcSEcCtD
Trandolapril—CES1—NRF2 pathway—ADH7—esophageal cancer	0.000526	0.0263	CbGpPWpGaD
Trandolapril—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000523	0.00441	CcSEcCtD
Trandolapril—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000521	0.00439	CcSEcCtD
Trandolapril—Migraine—Capecitabine—esophageal cancer	0.000519	0.00437	CcSEcCtD
Trandolapril—Bradycardia—Cisplatin—esophageal cancer	0.000504	0.00424	CcSEcCtD
Trandolapril—Cardiac arrest—Capecitabine—esophageal cancer	0.000502	0.00422	CcSEcCtD
Trandolapril—Blood creatinine increased—Capecitabine—esophageal cancer	0.000494	0.00416	CcSEcCtD
Trandolapril—Urine output increased—Methotrexate—esophageal cancer	0.000489	0.00412	CcSEcCtD
Trandolapril—Urinary tract disorder—Cisplatin—esophageal cancer	0.000489	0.00412	CcSEcCtD
Trandolapril—Liver function test abnormal—Capecitabine—esophageal cancer	0.000487	0.0041	CcSEcCtD
Trandolapril—Connective tissue disorder—Cisplatin—esophageal cancer	0.000486	0.0041	CcSEcCtD
Trandolapril—Urethral disorder—Cisplatin—esophageal cancer	0.000485	0.00409	CcSEcCtD
Trandolapril—Dry skin—Capecitabine—esophageal cancer	0.000483	0.00407	CcSEcCtD
Trandolapril—Visual impairment—Cisplatin—esophageal cancer	0.000477	0.00402	CcSEcCtD
Trandolapril—Breast disorder—Capecitabine—esophageal cancer	0.000477	0.00401	CcSEcCtD
Trandolapril—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000475	0.004	CcSEcCtD
Trandolapril—Gastritis—Capecitabine—esophageal cancer	0.000467	0.00393	CcSEcCtD
Trandolapril—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000465	0.00392	CcSEcCtD
Trandolapril—Eye disorder—Cisplatin—esophageal cancer	0.000463	0.0039	CcSEcCtD
Trandolapril—Tinnitus—Cisplatin—esophageal cancer	0.000462	0.00389	CcSEcCtD
Trandolapril—Cardiac disorder—Cisplatin—esophageal cancer	0.000459	0.00387	CcSEcCtD
Trandolapril—Flushing—Cisplatin—esophageal cancer	0.000459	0.00387	CcSEcCtD
Trandolapril—Abdominal distension—Capecitabine—esophageal cancer	0.000459	0.00387	CcSEcCtD
Trandolapril—ACE—Peptide hormone metabolism—GHRL—esophageal cancer	0.000454	0.0227	CbGpPWpGaD
Trandolapril—Perindopril—ABCB1—esophageal cancer	0.000451	0.232	CrCbGaD
Trandolapril—Photosensitivity—Methotrexate—esophageal cancer	0.000447	0.00377	CcSEcCtD
Trandolapril—Polyuria—Methotrexate—esophageal cancer	0.000447	0.00377	CcSEcCtD
Trandolapril—Immune system disorder—Cisplatin—esophageal cancer	0.000447	0.00377	CcSEcCtD
Trandolapril—Mediastinal disorder—Cisplatin—esophageal cancer	0.000446	0.00376	CcSEcCtD
Trandolapril—Angina pectoris—Capecitabine—esophageal cancer	0.000444	0.00374	CcSEcCtD
Trandolapril—Arrhythmia—Cisplatin—esophageal cancer	0.000442	0.00372	CcSEcCtD
Trandolapril—Bronchitis—Capecitabine—esophageal cancer	0.000438	0.00369	CcSEcCtD
Trandolapril—Alopecia—Cisplatin—esophageal cancer	0.000437	0.00368	CcSEcCtD
Trandolapril—Pancytopenia—Capecitabine—esophageal cancer	0.000433	0.00365	CcSEcCtD
Trandolapril—Malnutrition—Cisplatin—esophageal cancer	0.000431	0.00363	CcSEcCtD
Trandolapril—Neutropenia—Capecitabine—esophageal cancer	0.000426	0.00359	CcSEcCtD
Trandolapril—Renal failure acute—Methotrexate—esophageal cancer	0.000425	0.00358	CcSEcCtD
Trandolapril—Flatulence—Cisplatin—esophageal cancer	0.000425	0.00358	CcSEcCtD
Trandolapril—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000424	0.00357	CcSEcCtD
Trandolapril—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000416	0.0035	CcSEcCtD
Trandolapril—Visual disturbance—Methotrexate—esophageal cancer	0.000414	0.00349	CcSEcCtD
Trandolapril—Muscle spasms—Cisplatin—esophageal cancer	0.000414	0.00349	CcSEcCtD
Trandolapril—Hyperglycaemia—Capecitabine—esophageal cancer	0.000411	0.00346	CcSEcCtD
Trandolapril—Nateglinide—PTGS1—esophageal cancer	0.00041	0.21	CrCbGaD
Trandolapril—Infestation—Capecitabine—esophageal cancer	0.000406	0.00342	CcSEcCtD
Trandolapril—Infestation NOS—Capecitabine—esophageal cancer	0.000406	0.00342	CcSEcCtD
Trandolapril—Depression—Capecitabine—esophageal cancer	0.000405	0.00341	CcSEcCtD
Trandolapril—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000403	0.00339	CcSEcCtD
Trandolapril—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000401	0.00337	CcSEcCtD
Trandolapril—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000401	0.00337	CcSEcCtD
Trandolapril—Ill-defined disorder—Cisplatin—esophageal cancer	0.0004	0.00337	CcSEcCtD
Trandolapril—Renal failure—Capecitabine—esophageal cancer	0.0004	0.00337	CcSEcCtD
Trandolapril—Myocardial infarction—Capecitabine—esophageal cancer	0.000398	0.00336	CcSEcCtD
Trandolapril—Anaemia—Cisplatin—esophageal cancer	0.000398	0.00335	CcSEcCtD
Trandolapril—Lisinopril—ABCB1—esophageal cancer	0.000398	0.204	CrCbGaD
Trandolapril—Cilazapril—ABCB1—esophageal cancer	0.000398	0.204	CrCbGaD
Trandolapril—Urinary tract infection—Capecitabine—esophageal cancer	0.000395	0.00333	CcSEcCtD
Trandolapril—Osteoarthritis—Methotrexate—esophageal cancer	0.000393	0.00331	CcSEcCtD
Trandolapril—Malaise—Cisplatin—esophageal cancer	0.000389	0.00327	CcSEcCtD
Trandolapril—Leukopenia—Cisplatin—esophageal cancer	0.000386	0.00325	CcSEcCtD
Trandolapril—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000384	0.00324	CcSEcCtD
Trandolapril—Epistaxis—Capecitabine—esophageal cancer	0.000383	0.00323	CcSEcCtD
Trandolapril—CES1—NRF2 pathway—ABCC2—esophageal cancer	0.000382	0.0191	CbGpPWpGaD
Trandolapril—Agranulocytosis—Capecitabine—esophageal cancer	0.000379	0.00319	CcSEcCtD
Trandolapril—Bradycardia—Capecitabine—esophageal cancer	0.000371	0.00313	CcSEcCtD
Trandolapril—Myalgia—Cisplatin—esophageal cancer	0.000367	0.00309	CcSEcCtD
Trandolapril—Rhinitis—Capecitabine—esophageal cancer	0.000366	0.00308	CcSEcCtD
Trandolapril—Anxiety—Cisplatin—esophageal cancer	0.000366	0.00308	CcSEcCtD
Trandolapril—Hepatitis—Capecitabine—esophageal cancer	0.000365	0.00307	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000364	0.00307	CcSEcCtD
Trandolapril—Liver function test abnormal—Methotrexate—esophageal cancer	0.000363	0.00305	CcSEcCtD
Trandolapril—Discomfort—Cisplatin—esophageal cancer	0.000362	0.00305	CcSEcCtD
Trandolapril—Pharyngitis—Capecitabine—esophageal cancer	0.000362	0.00305	CcSEcCtD
Trandolapril—Urinary tract disorder—Capecitabine—esophageal cancer	0.00036	0.00304	CcSEcCtD
Trandolapril—Oedema peripheral—Capecitabine—esophageal cancer	0.000359	0.00303	CcSEcCtD
Trandolapril—Connective tissue disorder—Capecitabine—esophageal cancer	0.000359	0.00302	CcSEcCtD
Trandolapril—Urethral disorder—Capecitabine—esophageal cancer	0.000358	0.00301	CcSEcCtD
Trandolapril—CES1—NRF2 pathway—NFE2L2—esophageal cancer	0.000355	0.0178	CbGpPWpGaD
Trandolapril—Breast disorder—Methotrexate—esophageal cancer	0.000355	0.00299	CcSEcCtD
Trandolapril—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000354	0.00298	CcSEcCtD
Trandolapril—Oedema—Cisplatin—esophageal cancer	0.000352	0.00296	CcSEcCtD
Trandolapril—Visual impairment—Capecitabine—esophageal cancer	0.000352	0.00296	CcSEcCtD
Trandolapril—Infection—Cisplatin—esophageal cancer	0.000349	0.00294	CcSEcCtD
Trandolapril—Erythema multiforme—Capecitabine—esophageal cancer	0.000345	0.00291	CcSEcCtD
Trandolapril—Nervous system disorder—Cisplatin—esophageal cancer	0.000345	0.0029	CcSEcCtD
Trandolapril—Thrombocytopenia—Cisplatin—esophageal cancer	0.000344	0.0029	CcSEcCtD
Trandolapril—Tachycardia—Cisplatin—esophageal cancer	0.000343	0.00289	CcSEcCtD
Trandolapril—Skin disorder—Cisplatin—esophageal cancer	0.000342	0.00288	CcSEcCtD
Trandolapril—Eye disorder—Capecitabine—esophageal cancer	0.000341	0.00287	CcSEcCtD
Trandolapril—Tinnitus—Capecitabine—esophageal cancer	0.00034	0.00287	CcSEcCtD
Trandolapril—Hyperhidrosis—Cisplatin—esophageal cancer	0.00034	0.00286	CcSEcCtD
Trandolapril—Cardiac disorder—Capecitabine—esophageal cancer	0.000339	0.00285	CcSEcCtD
Trandolapril—Flushing—Capecitabine—esophageal cancer	0.000339	0.00285	CcSEcCtD
Trandolapril—Eosinophilia—Methotrexate—esophageal cancer	0.000336	0.00283	CcSEcCtD
Trandolapril—Anorexia—Cisplatin—esophageal cancer	0.000335	0.00282	CcSEcCtD
Trandolapril—Pancreatitis—Methotrexate—esophageal cancer	0.000333	0.0028	CcSEcCtD
Trandolapril—Angiopathy—Capecitabine—esophageal cancer	0.000331	0.00279	CcSEcCtD
Trandolapril—Immune system disorder—Capecitabine—esophageal cancer	0.00033	0.00278	CcSEcCtD
Trandolapril—Mediastinal disorder—Capecitabine—esophageal cancer	0.000329	0.00277	CcSEcCtD
Trandolapril—Hypotension—Cisplatin—esophageal cancer	0.000329	0.00277	CcSEcCtD
Trandolapril—Arrhythmia—Capecitabine—esophageal cancer	0.000326	0.00275	CcSEcCtD
Trandolapril—Alopecia—Capecitabine—esophageal cancer	0.000322	0.00272	CcSEcCtD
Trandolapril—Pancytopenia—Methotrexate—esophageal cancer	0.000322	0.00271	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00032	0.0027	CcSEcCtD
Trandolapril—Mental disorder—Capecitabine—esophageal cancer	0.00032	0.00269	CcSEcCtD
Trandolapril—Malnutrition—Capecitabine—esophageal cancer	0.000318	0.00268	CcSEcCtD
Trandolapril—Neutropenia—Methotrexate—esophageal cancer	0.000317	0.00267	CcSEcCtD
Trandolapril—Paraesthesia—Cisplatin—esophageal cancer	0.000316	0.00266	CcSEcCtD
Trandolapril—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000315	0.00266	CcSEcCtD
Trandolapril—Dyspnoea—Cisplatin—esophageal cancer	0.000314	0.00264	CcSEcCtD
Trandolapril—Flatulence—Capecitabine—esophageal cancer	0.000313	0.00264	CcSEcCtD
Trandolapril—Erectile dysfunction—Methotrexate—esophageal cancer	0.000313	0.00263	CcSEcCtD
Trandolapril—Dysgeusia—Capecitabine—esophageal cancer	0.000311	0.00262	CcSEcCtD
Trandolapril—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00031	0.00261	CcSEcCtD
Trandolapril—Back pain—Capecitabine—esophageal cancer	0.000307	0.00259	CcSEcCtD
Trandolapril—Decreased appetite—Cisplatin—esophageal cancer	0.000306	0.00257	CcSEcCtD
Trandolapril—CES1—NRF2 pathway—CYP2A6—esophageal cancer	0.000305	0.0153	CbGpPWpGaD
Trandolapril—Muscle spasms—Capecitabine—esophageal cancer	0.000305	0.00257	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000304	0.00256	CcSEcCtD
Trandolapril—Drowsiness—Methotrexate—esophageal cancer	0.000303	0.00255	CcSEcCtD
Trandolapril—Infestation NOS—Methotrexate—esophageal cancer	0.000303	0.00255	CcSEcCtD
Trandolapril—Infestation—Methotrexate—esophageal cancer	0.000303	0.00255	CcSEcCtD
Trandolapril—Depression—Methotrexate—esophageal cancer	0.000302	0.00254	CcSEcCtD
Trandolapril—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.0003	0.00253	CcSEcCtD
Trandolapril—Renal failure—Methotrexate—esophageal cancer	0.000297	0.00251	CcSEcCtD
Trandolapril—Ill-defined disorder—Capecitabine—esophageal cancer	0.000295	0.00248	CcSEcCtD
Trandolapril—Anaemia—Capecitabine—esophageal cancer	0.000294	0.00247	CcSEcCtD
Trandolapril—Enalapril—ABCB1—esophageal cancer	0.000292	0.15	CrCbGaD
Trandolapril—Sweating—Methotrexate—esophageal cancer	0.00029	0.00244	CcSEcCtD
Trandolapril—Feeling abnormal—Cisplatin—esophageal cancer	0.00029	0.00244	CcSEcCtD
Trandolapril—Malaise—Capecitabine—esophageal cancer	0.000286	0.00241	CcSEcCtD
Trandolapril—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000286	0.00241	CcSEcCtD
Trandolapril—Epistaxis—Methotrexate—esophageal cancer	0.000285	0.0024	CcSEcCtD
Trandolapril—Vertigo—Capecitabine—esophageal cancer	0.000285	0.0024	CcSEcCtD
Trandolapril—Syncope—Capecitabine—esophageal cancer	0.000285	0.0024	CcSEcCtD
Trandolapril—Leukopenia—Capecitabine—esophageal cancer	0.000284	0.00239	CcSEcCtD
Trandolapril—Agranulocytosis—Methotrexate—esophageal cancer	0.000282	0.00238	CcSEcCtD
Trandolapril—Palpitations—Capecitabine—esophageal cancer	0.000281	0.00236	CcSEcCtD
Trandolapril—Loss of consciousness—Capecitabine—esophageal cancer	0.000279	0.00235	CcSEcCtD
Trandolapril—Body temperature increased—Cisplatin—esophageal cancer	0.000278	0.00234	CcSEcCtD
Trandolapril—Cough—Capecitabine—esophageal cancer	0.000277	0.00233	CcSEcCtD
Trandolapril—Hepatitis—Methotrexate—esophageal cancer	0.000272	0.00229	CcSEcCtD
Trandolapril—Chest pain—Capecitabine—esophageal cancer	0.00027	0.00228	CcSEcCtD
Trandolapril—Arthralgia—Capecitabine—esophageal cancer	0.00027	0.00228	CcSEcCtD
Trandolapril—Myalgia—Capecitabine—esophageal cancer	0.00027	0.00228	CcSEcCtD
Trandolapril—Pharyngitis—Methotrexate—esophageal cancer	0.00027	0.00227	CcSEcCtD
Trandolapril—Anxiety—Capecitabine—esophageal cancer	0.000269	0.00227	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000269	0.00226	CcSEcCtD
Trandolapril—Urinary tract disorder—Methotrexate—esophageal cancer	0.000268	0.00226	CcSEcCtD
Trandolapril—Discomfort—Capecitabine—esophageal cancer	0.000267	0.00225	CcSEcCtD
Trandolapril—Urethral disorder—Methotrexate—esophageal cancer	0.000266	0.00224	CcSEcCtD
Trandolapril—Dry mouth—Capecitabine—esophageal cancer	0.000264	0.00223	CcSEcCtD
Trandolapril—Visual impairment—Methotrexate—esophageal cancer	0.000262	0.0022	CcSEcCtD
Trandolapril—Oedema—Capecitabine—esophageal cancer	0.000259	0.00218	CcSEcCtD
Trandolapril—Hypersensitivity—Cisplatin—esophageal cancer	0.000259	0.00218	CcSEcCtD
Trandolapril—Infection—Capecitabine—esophageal cancer	0.000258	0.00217	CcSEcCtD
Trandolapril—Erythema multiforme—Methotrexate—esophageal cancer	0.000257	0.00216	CcSEcCtD
Trandolapril—Shock—Capecitabine—esophageal cancer	0.000255	0.00215	CcSEcCtD
Trandolapril—Nervous system disorder—Capecitabine—esophageal cancer	0.000254	0.00214	CcSEcCtD
Trandolapril—Eye disorder—Methotrexate—esophageal cancer	0.000254	0.00214	CcSEcCtD
Trandolapril—Thrombocytopenia—Capecitabine—esophageal cancer	0.000254	0.00214	CcSEcCtD
Trandolapril—Tinnitus—Methotrexate—esophageal cancer	0.000253	0.00213	CcSEcCtD
Trandolapril—Tachycardia—Capecitabine—esophageal cancer	0.000253	0.00213	CcSEcCtD
Trandolapril—Asthenia—Cisplatin—esophageal cancer	0.000252	0.00213	CcSEcCtD
Trandolapril—Cardiac disorder—Methotrexate—esophageal cancer	0.000252	0.00212	CcSEcCtD
Trandolapril—Skin disorder—Capecitabine—esophageal cancer	0.000252	0.00212	CcSEcCtD
Trandolapril—Hyperhidrosis—Capecitabine—esophageal cancer	0.000251	0.00211	CcSEcCtD
Trandolapril—Anorexia—Capecitabine—esophageal cancer	0.000247	0.00208	CcSEcCtD
Trandolapril—Angiopathy—Methotrexate—esophageal cancer	0.000246	0.00208	CcSEcCtD
Trandolapril—Immune system disorder—Methotrexate—esophageal cancer	0.000245	0.00207	CcSEcCtD
Trandolapril—Mediastinal disorder—Methotrexate—esophageal cancer	0.000245	0.00206	CcSEcCtD
Trandolapril—Hypotension—Capecitabine—esophageal cancer	0.000242	0.00204	CcSEcCtD
Trandolapril—Diarrhoea—Cisplatin—esophageal cancer	0.000241	0.00203	CcSEcCtD
Trandolapril—Alopecia—Methotrexate—esophageal cancer	0.00024	0.00202	CcSEcCtD
Trandolapril—Mental disorder—Methotrexate—esophageal cancer	0.000238	0.002	CcSEcCtD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000237	0.0119	CbGpPWpGaD
Trandolapril—Malnutrition—Methotrexate—esophageal cancer	0.000236	0.00199	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000236	0.00199	CcSEcCtD
Trandolapril—CES1—E2F transcription factor network—CREBBP—esophageal cancer	0.000236	0.0118	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—RB1—esophageal cancer	0.000235	0.0118	CbGpPWpGaD
Trandolapril—Insomnia—Capecitabine—esophageal cancer	0.000234	0.00197	CcSEcCtD
Trandolapril—Paraesthesia—Capecitabine—esophageal cancer	0.000233	0.00196	CcSEcCtD
Trandolapril—Dysgeusia—Methotrexate—esophageal cancer	0.000232	0.00195	CcSEcCtD
Trandolapril—Dyspnoea—Capecitabine—esophageal cancer	0.000231	0.00195	CcSEcCtD
Trandolapril—Back pain—Methotrexate—esophageal cancer	0.000229	0.00193	CcSEcCtD
Trandolapril—Dyspepsia—Capecitabine—esophageal cancer	0.000228	0.00192	CcSEcCtD
Trandolapril—Decreased appetite—Capecitabine—esophageal cancer	0.000225	0.0019	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000224	0.00189	CcSEcCtD
Trandolapril—Vomiting—Cisplatin—esophageal cancer	0.000224	0.00188	CcSEcCtD
Trandolapril—Fatigue—Capecitabine—esophageal cancer	0.000224	0.00188	CcSEcCtD
Trandolapril—Rash—Cisplatin—esophageal cancer	0.000222	0.00187	CcSEcCtD
Trandolapril—Constipation—Capecitabine—esophageal cancer	0.000222	0.00187	CcSEcCtD
Trandolapril—Dermatitis—Cisplatin—esophageal cancer	0.000222	0.00187	CcSEcCtD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.00022	0.011	CbGpPWpGaD
Trandolapril—Ill-defined disorder—Methotrexate—esophageal cancer	0.000219	0.00185	CcSEcCtD
Trandolapril—Anaemia—Methotrexate—esophageal cancer	0.000219	0.00184	CcSEcCtD
Trandolapril—CES1—Fluoropyrimidine Activity—TP53—esophageal cancer	0.000217	0.0109	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000217	0.0108	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—TGFBR2—esophageal cancer	0.000214	0.0107	CbGpPWpGaD
Trandolapril—Feeling abnormal—Capecitabine—esophageal cancer	0.000214	0.0018	CcSEcCtD
Trandolapril—Malaise—Methotrexate—esophageal cancer	0.000213	0.0018	CcSEcCtD
Trandolapril—Vertigo—Methotrexate—esophageal cancer	0.000212	0.00179	CcSEcCtD
Trandolapril—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000212	0.00179	CcSEcCtD
Trandolapril—Leukopenia—Methotrexate—esophageal cancer	0.000212	0.00178	CcSEcCtD
Trandolapril—CES1—NRF2 pathway—HMOX1—esophageal cancer	0.000211	0.0106	CbGpPWpGaD
Trandolapril—Nausea—Cisplatin—esophageal cancer	0.000209	0.00176	CcSEcCtD
Trandolapril—CES1—E2F transcription factor network—CDKN2A—esophageal cancer	0.000207	0.0103	CbGpPWpGaD
Trandolapril—Cough—Methotrexate—esophageal cancer	0.000206	0.00174	CcSEcCtD
Trandolapril—Urticaria—Capecitabine—esophageal cancer	0.000206	0.00173	CcSEcCtD
Trandolapril—Abdominal pain—Capecitabine—esophageal cancer	0.000205	0.00173	CcSEcCtD
Trandolapril—Body temperature increased—Capecitabine—esophageal cancer	0.000205	0.00173	CcSEcCtD
Trandolapril—Myalgia—Methotrexate—esophageal cancer	0.000201	0.0017	CcSEcCtD
Trandolapril—Chest pain—Methotrexate—esophageal cancer	0.000201	0.0017	CcSEcCtD
Trandolapril—Arthralgia—Methotrexate—esophageal cancer	0.000201	0.0017	CcSEcCtD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000201	0.0101	CbGpPWpGaD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.0002	0.00168	CcSEcCtD
Trandolapril—Discomfort—Methotrexate—esophageal cancer	0.000199	0.00168	CcSEcCtD
Trandolapril—Infection—Methotrexate—esophageal cancer	0.000192	0.00161	CcSEcCtD
Trandolapril—Hypersensitivity—Capecitabine—esophageal cancer	0.000191	0.00161	CcSEcCtD
Trandolapril—Nervous system disorder—Methotrexate—esophageal cancer	0.000189	0.00159	CcSEcCtD
Trandolapril—Thrombocytopenia—Methotrexate—esophageal cancer	0.000189	0.00159	CcSEcCtD
Trandolapril—Skin disorder—Methotrexate—esophageal cancer	0.000187	0.00158	CcSEcCtD
Trandolapril—Hyperhidrosis—Methotrexate—esophageal cancer	0.000187	0.00157	CcSEcCtD
Trandolapril—Asthenia—Capecitabine—esophageal cancer	0.000186	0.00157	CcSEcCtD
Trandolapril—Anorexia—Methotrexate—esophageal cancer	0.000184	0.00155	CcSEcCtD
Trandolapril—Pruritus—Capecitabine—esophageal cancer	0.000183	0.00154	CcSEcCtD
Trandolapril—Hypotension—Methotrexate—esophageal cancer	0.00018	0.00152	CcSEcCtD
Trandolapril—Diarrhoea—Capecitabine—esophageal cancer	0.000177	0.00149	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000176	0.00148	CcSEcCtD
Trandolapril—Insomnia—Methotrexate—esophageal cancer	0.000175	0.00147	CcSEcCtD
Trandolapril—Paraesthesia—Methotrexate—esophageal cancer	0.000173	0.00146	CcSEcCtD
Trandolapril—Dyspnoea—Methotrexate—esophageal cancer	0.000172	0.00145	CcSEcCtD
Trandolapril—Somnolence—Methotrexate—esophageal cancer	0.000172	0.00144	CcSEcCtD
Trandolapril—Dizziness—Capecitabine—esophageal cancer	0.000171	0.00144	CcSEcCtD
Trandolapril—Dyspepsia—Methotrexate—esophageal cancer	0.00017	0.00143	CcSEcCtD
Trandolapril—CES1—E2F transcription factor network—CDKN1A—esophageal cancer	0.000169	0.00845	CbGpPWpGaD
Trandolapril—Decreased appetite—Methotrexate—esophageal cancer	0.000168	0.00141	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—XBP1—esophageal cancer	0.000167	0.00837	CbGpPWpGaD
Trandolapril—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000167	0.0014	CcSEcCtD
Trandolapril—Fatigue—Methotrexate—esophageal cancer	0.000166	0.0014	CcSEcCtD
Trandolapril—Vomiting—Capecitabine—esophageal cancer	0.000165	0.00139	CcSEcCtD
Trandolapril—Rash—Capecitabine—esophageal cancer	0.000163	0.00138	CcSEcCtD
Trandolapril—Dermatitis—Capecitabine—esophageal cancer	0.000163	0.00138	CcSEcCtD
Trandolapril—Headache—Capecitabine—esophageal cancer	0.000162	0.00137	CcSEcCtD
Trandolapril—CES1—E2F transcription factor network—EP300—esophageal cancer	0.000161	0.00804	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—SLC30A7—esophageal cancer	0.00016	0.00803	CbGpPWpGaD
Trandolapril—Feeling abnormal—Methotrexate—esophageal cancer	0.000159	0.00134	CcSEcCtD
Trandolapril—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000158	0.00133	CcSEcCtD
Trandolapril—Nausea—Capecitabine—esophageal cancer	0.000154	0.0013	CcSEcCtD
Trandolapril—Urticaria—Methotrexate—esophageal cancer	0.000153	0.00129	CcSEcCtD
Trandolapril—Body temperature increased—Methotrexate—esophageal cancer	0.000153	0.00128	CcSEcCtD
Trandolapril—Abdominal pain—Methotrexate—esophageal cancer	0.000153	0.00128	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—ST6GAL1—esophageal cancer	0.000144	0.00723	CbGpPWpGaD
Trandolapril—Hypersensitivity—Methotrexate—esophageal cancer	0.000142	0.0012	CcSEcCtD
Trandolapril—CES1—E2F transcription factor network—MYC—esophageal cancer	0.00014	0.007	CbGpPWpGaD
Trandolapril—Asthenia—Methotrexate—esophageal cancer	0.000138	0.00117	CcSEcCtD
Trandolapril—Pruritus—Methotrexate—esophageal cancer	0.000137	0.00115	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000135	0.00676	CbGpPWpGaD
Trandolapril—Diarrhoea—Methotrexate—esophageal cancer	0.000132	0.00111	CcSEcCtD
Trandolapril—Dizziness—Methotrexate—esophageal cancer	0.000128	0.00107	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000127	0.00636	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000125	0.00627	CbGpPWpGaD
Trandolapril—Vomiting—Methotrexate—esophageal cancer	0.000123	0.00103	CcSEcCtD
Trandolapril—Rash—Methotrexate—esophageal cancer	0.000122	0.00102	CcSEcCtD
Trandolapril—Dermatitis—Methotrexate—esophageal cancer	0.000122	0.00102	CcSEcCtD
Trandolapril—Headache—Methotrexate—esophageal cancer	0.000121	0.00102	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.00012	0.00603	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000118	0.0059	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000115	0.00575	CbGpPWpGaD
Trandolapril—Nausea—Methotrexate—esophageal cancer	0.000115	0.000965	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000112	0.00559	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.00011	0.00551	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.00011	0.00551	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000107	0.00534	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000102	0.00512	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000102	0.00512	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—ACTB—esophageal cancer	9.95e-05	0.00498	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—HSPA5—esophageal cancer	8.99e-05	0.0045	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—CALR—esophageal cancer	8.71e-05	0.00436	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—GHRL—esophageal cancer	8.57e-05	0.00429	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—FBXW7—esophageal cancer	8.43e-05	0.00422	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	8.35e-05	0.00418	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	7.75e-05	0.00388	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—GNG7—esophageal cancer	7.58e-05	0.00379	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—GNG7—esophageal cancer	7.03e-05	0.00352	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.62e-05	0.00231	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	4.43e-05	0.00222	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.28e-05	0.00214	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	4.11e-05	0.00206	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.96e-05	0.00148	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.75e-05	0.00137	CbGpPWpGaD
